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Wiszniewski et al., page 197
Owing to demographic history, many genomic alterations
are found in isolated groups of individuals. In this issue,
Wiszniewski et al. describe a population-specific deletion
within TM4SF20, a gene that encodes a transmembrane
protein of unknown function. The deletion results in a
premature stop codon and an apparent alteration in
protein localization. Affected individuals experience early
language delay, and brain MRIs show white-matter hyper-
intensities (WMHs), a sign usually associated with prema-
ture aging. However, the WMHs do not appear to have
a long-term negative impact; in fact, many individuals
harboring this mutation have gone on to attain a high
level of education. How might this apparently deleterious
mutation have reached such a high frequency (up to 1%
frequency in the Vietnamese Kinh)? One might look to
history and cultural mores. Without a doubt, it is a special
time when a child begins to acquire language skills, and
now more than ever, parents worry whether their child is
among the group of early talkers. But in a population in
which children are supposed to be seen and not heard,
would a language delay be viewed as detrimental (or
even be noticed at all)?Imprinted Splicing
Niemczyk et al., page 224
Imprinting, the process by which expression from either
the maternal or the paternal allele is silenced, plays a role
in many developmental processes. Imprinted genes
contribute to cell proliferation or fetal growth, and so it
is not surprising that aberrant imprinting has been impli-
cated in tumorigenesis. In one such example, loss of
imprinting is observed for DIRAS3 in several cancers. This
tumor suppressor lies within an intron of a relatively
uncharacterized long noncoding RNA (lncRNA), GNG12-
AS1. To explore whether this gene pair is coordinately
regulated, Niemczyk et al. assessed their imprinting status
in normal and cancer cells. In normal cells, whereas
DIRAS3 is expressed from the paternal allele, the authors
found that GNG12-AS1 is biallelically expressed but
undergoes allele-specific splicing. Inclusion of exon 2 is
seen only from thematernal allele;DIRAS3 resides between
exons 2 and 3. However, when DIRAS3 imprinting is lost,1Scientific Editor, AJHG; 2Deputy Editor, AJHG
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nates only from the maternal allele. These findings led
the authors to propose a model in which DIRAS3 ex-
pression regulates both the splicing and the transcription
of GNG12-AS1. Many questions remain regarding the
mechanism by which this imprinted splicing occurs, but
the unique properties of this locus suggest that it will
provide a good model system for future study of coordi-
nated gene expression.A miRacle in the Fight against Huntington
Disease?
Cheng et al., page 264
Huntington disease (HD), a neurodegenerative disorder
with no known cure, is caused by a repeat expansion
within HTT. Although the exact mechanism of toxicity
remains unknown, work in recent years has indicated
that decreasing protein production could be a promising
therapeutic strategy. To this end, many groups are focused
on the development of antisense oligonucleotides that
directly target HTT. In this issue, however, Cheng et al.
show that miR-196a can suppress the deleterious effects
of HTT expression—without directly targeting HTT. A
previous study showed that this miRNA, whose expression
is enriched in the brain and which targets a HTT binding
partner, is downregulated in HD. New experiments in
mice indicate that transgenic miR-196a expression de-
creases HTT levels and improves a variety of neuropatho-
logical phenotypes. Similarly, iPS cells derived from
affected individuals display reduced aggregate formation
in response to miR-196a expression. Although further
work is needed for better understanding the mechanism
by which miR-196a exerts its protective effect—especially
in terms of defining the targets that ultimately lead to
decreased pathological phenotypes—these findings pro-
vide another entry point in the development of therapeu-
tic strategies for combatting this devastating disease.Refining Gene-Disease Associations in X-Linked
Intellectual Disability
Piton et al., page 368
Exome sequencing has uncovered the genetic basis of
many diseases. However, for diseases caused by mutationsy of Human Genetics. All rights reserved.
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in many genes, such as X-linked intellectual disability
(XLID), it can be difficult to assign pathogenicity of a
mutation in a previously unreported gene. As exome-
sequencing databases become available for unrelated
disorders, the frequency of mutations in genes that
might be associated with a disease can be evaluated. For
example, the National Heart, Lung, and Blood Institute
Exome Sequencing Project Exome Variant Server (NHLBI
EVS), which selected individuals for cardiac, lung, or
metabolic phenotypes, could also serve as a control popu-
lation for XLID because it is unlikely that XLID-affected
males would have been included in this cohort. In this
study, Piton et al. systematically reevaluate the patho-
genicity of over 100 genes reportedly associated with
XLID by searching the NHLBI EVS for the prevalence of
mutations in these genes, especially truncating loss-of-
function mutations in males. On the basis of this analysis,
they propose that the associations between XLID and
previously reported XLID-causing mutations in AGTR2,
MAGT1, ZNF674, SRPX2, ATP6AP2, ARHGEF6, NXF5,
ZCCHC12 (SIZN1), ZNF41, and ZNF81 are questionable;
they also question 15 genes in which mutations have
never been replicated. They caution against prematurely
assigning pathogenicity to mutations in these genes.
Not only does this study help to refine the gene-disease
associations in XLID, but it also provides an example
of the type of iterative analysis that is necessary for
many diseases as extensive sequencing data become
available.194 The American Journal of Human Genetics 93, 193–194, August 8Taking on Water
Blaydon et al., page 330
The skin barrier helps to protect an organism by limiting
the uptake and loss of environmental substances, especially
water. Several human skin diseases are associated with
increased water loss, but there are fewer diseases that result
in increasedwater uptake. One family of diseases that result
in defective water homeostasis is the inherited palmoplan-
ter keratodermas (PPK), in which the skin on the palms and
feet becomes thickened; in some forms, such as nonepider-
molytic PPK (NEPPK), the affected areas have a white,
spongy appearance after exposure to water. Additionally,
NEPPK results in increased water uptake. In this study,
Blaydon et al. used a combined approachof linkage analysis
and exome sequencing to identify missense mutations in
AQP5 as a cause of NEPPK. AQP5 encodes a water-channel
protein that allows water to move across the cell mem-
brane. Because the channel must be localized to the
membrane to transport water, the authors determined the
cellular localization of the altered proteins. Like the wild-
type, the altered AQP5 proteins were identified on the
plasma membrane, suggesting that they might still be
capable ofwater transport and that the amino acid substitu-
tions alter the permeability of the channel to allow more
water to pass into the cell. Knowing the cause of NEPPK
might allow for the development of therapies for skin-bar-
rier deficiencies; it also tells us a little more about the
wrinkly fingers that come with being in the pool too long., 2013
